These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16014120)

  • 1. Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger.
    Ota T; Yoshida M; Kimura M; Kinoshita K
    Int J Gynecol Cancer; 2005; 15(4):657-62. PubMed ID: 16014120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
    Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
    Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature.
    Ohyagi-Hara C; Sawada K; Aki I; Mabuchi S; Kobayashi E; Ueda Y; Yoshino K; Fujita M; Tsutsui T; Kimura T
    Arch Gynecol Obstet; 2015 Jan; 291(1):151-7. PubMed ID: 25118836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of fertility-sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone acetate.
    Nomura H; Sugiyama Y; Tanigawa T; Matoda M; Kanao H; Kondo E; Takeshima N
    Arch Gynecol Obstet; 2016 Jan; 293(1):177-181. PubMed ID: 26209972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate.
    Mitsushita J; Toki T; Kato K; Fujii S; Konishi I
    Gynecol Oncol; 2000 Oct; 79(1):129-32. PubMed ID: 11006045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal therapy for women with stage IA endometrial cancer of all grades.
    Park JY; Kim DY; Kim TJ; Kim JW; Kim JH; Kim YM; Kim YT; Bae DS; Nam JH
    Obstet Gynecol; 2013 Jul; 122(1):7-14. PubMed ID: 23743459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia.
    Inoue O; Hamatani T; Susumu N; Yamagami W; Ogawa S; Takemoto T; Hirasawa A; Banno K; Kuji N; Tanaka M; Aoki D
    Reprod Biol Endocrinol; 2016 Jan; 14():2. PubMed ID: 26769300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormonal therapy for endometrial adenocarcinoma].
    Susumu N; Aoki D; Suzuki N; Nozawa S
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):934-45. PubMed ID: 11478142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome.
    Kaku T; Yoshikawa H; Tsuda H; Sakamoto A; Fukunaga M; Kuwabara Y; Hataeg M; Kodama S; Kuzuya K; Sato S; Nishimura T; Hiura M; Nakano H; Iwasaka T; Miyazaki K; Kamura T
    Cancer Lett; 2001 Jun; 167(1):39-48. PubMed ID: 11323097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
    Park H; Seok JM; Yoon BS; Seong SJ; Kim JY; Shim JY; Park CT
    Arch Gynecol Obstet; 2012 Feb; 285(2):473-8. PubMed ID: 21706284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations.
    Imai M; Jobo T; Sato R; Kawaguchi M; Kuramoto H
    Eur J Gynaecol Oncol; 2001; 22(3):217-20. PubMed ID: 11501776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Zaino RJ; Brady WE; Todd W; Leslie K; Fischer EG; Horowitz NS; Mannel RS; Walker JL; Ivanovic M; Duska LR
    Int J Gynecol Pathol; 2014 Nov; 33(6):543-53. PubMed ID: 25272292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate?
    Vinker S; Shani A; Open M; Fenig E; Dgani R
    Eur J Obstet Gynecol Reprod Biol; 1999 Mar; 83(1):63-5. PubMed ID: 10221612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sparing fertility in young patients with endometrial cancer.
    Chiva L; Lapuente F; González-Cortijo L; Carballo N; García JF; Rojo A; Gonzalez-Martín A
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of conservative therapy for young women with early endometrial adenocarcinoma.
    Mao Y; Wan X; Chen Y; Lv W; Xie X
    Fertil Steril; 2010 Jan; 93(1):283-5. PubMed ID: 19962142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endometrial adenocarcinoma in women 40 years old or younger by treatment with progestins: report of 6 cases and review of the literatures].
    Wang HY; Shen L; Sun Z
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):237-41. PubMed ID: 16759457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
    Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
    Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.